XML 60 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets and Goodwill
3 Months Ended
Oct. 31, 2013
Intangible Assets and Goodwill  
Intangible Assets and Goodwill

Note 7.                   Intangible Assets and Goodwill

 

Our intangible assets with definite lives consist of customer relationships, technology, brand names, non-compete agreements and patents. These intangible assets are being amortized using the straight-line method over the estimated useful lives of the assets ranging from 2-20 years and have a weighted average amortization period of 11 years. Amortization expense related to definite lived intangible assets was $2,626,000 and $2,267,000 for the three months ended October 31, 2013 and 2012, respectively. Our intangible assets that have indefinite useful lives, and therefore are not amortized, consist of trademarks and trade names.

 

The Company’s intangible assets consist of the following:

 

 

 

October 31, 2013

 

 

 

 

 

Accumulated

 

 

 

 

 

Gross

 

Amortization

 

Net

 

Intangible assets with finite lives:

 

 

 

 

 

 

 

Customer relationships

 

$

71,846,000

 

$

(26,483,000

)

$

45,363,000

 

Technology

 

20,509,000

 

(9,730,000

)

10,779,000

 

Brand names

 

12,680,000

 

(8,392,000

)

4,288,000

 

Non-compete agreements

 

3,159,000

 

(603,000

)

2,556,000

 

Patents and other registrations

 

1,820,000

 

(653,000

)

1,167,000

 

 

 

110,014,000

 

(45,861,000

)

64,153,000

 

Trademarks and trade names

 

9,359,000

 

 

9,359,000

 

Total intangible assets

 

$

119,373,000

 

$

(45,861,000

)

$

73,512,000

 

 

 

 

July 31, 2013

 

 

 

 

 

Accumulated

 

 

 

 

 

Gross

 

Amortization

 

Net

 

Intangible assets with finite lives:

 

 

 

 

 

 

 

Customer relationships

 

$

72,142,000

 

$

(25,379,000

)

$

46,763,000

 

Technology

 

21,006,000

 

(9,642,000

)

11,364,000

 

Brand names

 

12,680,000

 

(8,045,000

)

4,635,000

 

Non-compete agreements

 

3,159,000

 

(541,000

)

2,618,000

 

Patents and other registrations

 

1,768,000

 

(606,000

)

1,162,000

 

 

 

110,755,000

 

(44,213,000

)

66,542,000

 

Trademarks and trade names

 

9,387,000

 

 

9,387,000

 

Total intangible assets

 

$

120,142,000

 

$

(44,213,000

)

$

75,929,000

 

 

Estimated amortization expense of our intangible assets for the remainder of fiscal 2014 and the next five years is as follows:

 

Nine month period ending July 31, 2014

 

$

7,856,000

 

Fiscal 2015

 

10,229,000

 

Fiscal 2016

 

6,989,000

 

Fiscal 2017

 

6,413,000

 

Fiscal 2018

 

6,136,000

 

Fiscal 2019

 

5,813,000

 

 

Goodwill changed during fiscal 2013 and the three months ended October 31, 2013 as follows:

 

 

 

 

 

Water

 

 

 

 

 

 

 

 

 

 

 

 

 

Purification

 

Healthcare

 

 

 

 

 

Total

 

 

 

Endoscopy

 

and Filtration

 

Disposables

 

Dialysis

 

Other

 

Goodwill

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, July 31, 2012

 

$

59,230,000

 

$

53,288,000

 

$

55,864,000

 

$

8,133,000

 

$

7,140,000

 

$

183,655,000

 

Acquisitions

 

 

4,043,000

 

24,244,000

 

 

 

28,287,000

 

Foreign currency translation

 

 

(152,000

)

 

 

(172,000

)

(324,000

)

Balance, July 31, 2013

 

59,230,000

 

57,179,000

 

80,108,000

 

8,133,000

 

6,968,000

 

211,618,000

 

Foreign currency translation

 

 

(87,000

)

 

 

(102,000

)

(189,000

)

Balance, October 31, 2013

 

$

59,230,000

 

$

57,092,000

 

$

80,108,000

 

$

8,133,000

 

$

6,866,000

 

$

211,429,000

 

 

On July 31, 2013, we performed impairment studies of the Company’s goodwill and indefinite lived trademarks and trade names and concluded that such assets were not impaired. While the results of these annual reviews have historically not indicated impairment, impairment reviews are highly dependent on management’s projections of our future operating results and cash flows (which management believes to be reasonable), discount rates based on the Company’s weighted average cost of capital and appropriate benchmark peer companies. Assumptions used in determining future operating results and cash flows include current and expected market conditions and future sales forecasts. Subsequent changes in these assumptions and estimates could result in future impairment. Although we consistently use the same methods in developing the assumptions and estimates underlying the fair value calculations, such estimates are uncertain by nature and can vary from actual results. At July 31, 2013, the average fair value of all of our reporting units exceeded book value by substantial amounts, except our Specialty Packaging segment, which had an average estimated fair value that approximated book value. At October 31, 2013, goodwill relating to our Specialty Packaging reporting unit was $6,866,000. We believe the most significant assumptions impacting the impairment assessment of Specialty Packaging relate to an assumed compounded annual sales growth of 10.7% and future operating efficiencies included in our projections of future operating results and cash flows of this segment, which projections are in excess of historical run rates. If future operating results and cash flows are substantially less than our projections, future impairment charges may be recorded. On October 31, 2013, management concluded that no events or changes in circumstances have occurred during the three months ended October 31, 2013 that would indicate that the carrying amount of our intangible assets and goodwill may not be recoverable.